Managing Partner, Ramsey International, LLC
Mark provides advisory services to global organizations in the design and delivery of an ecosystem of best-in-class technologies to deliver production level, large scale data & analytics solutions. Implementing a solid data strategy in support of AI & Machine Learning can be complex. It is critical that organizations develop a modern data management platform as the foundation to provide analytics ready internal and external data.
Mark was the first R&D Chief Data & Analytics Officer for GlaxoSmithKline plc, a multinational pharmaceutical company headquartered in London, and the world’s sixth-largest pharmaceutical company. Mark led the design and implementation of the R&D Information Platform (RDIP) as a key component of the data strategy for the organization, delivering a range of analytic services from GWAS on UK Biobank and 23andMe data, standardized assay data, standardized clinical trial data, and consolidated portfolio data for R&D.
Mark was the first Chief Data Officer (CDO) for Samsung Telecommunications America. Previously, led the growth strategy, development and launch of the IBM Business Analytics & Optimization business spanning over 150 countries with an of over 2,000 consultants with annual revenues exceeding $800m and a Cagr of over 80%.
Dr. Ramsey is an inventor for the patent on the integration of data mining within a parallel relational database and the use of advanced analytics for user behavior monitoring as well as 27 other patents and numerous patent-pending filings in the area of data analytics and optimization.